Suchan M, Kaliarik L, Krempaska S, Koval J
Bratisl Lek Listy. 2016;117(2):87-90. doi: 10.4149/bll_2016_017.
The aim of this study is to prove the involvement of the immune response in the etiopathogenesis of some cochleovestibular disorders by a demonstration of antibodies against inner ear antigens and identify the benefits of immunosuppressive therapy.
McCabe in 1979 postulated the hypothesis of autoimmune inner ear disease.
Sodium dodecyl sulfate polyacrylamid gel electrophoresis and immunoblotting were used to examine the serum of 74 subjects for the presence of antibodies against inner ear antigens. The subjects were divided into three groups: A--subjects with idiopathic progressive sensorineural hearing loss, B--subjects with Menière´s disease, C--healthy subjects. Individuals with proven antibodies received immunosuppressive therapy.
We detected antibodies against inner ear antigens with molecular weight of 30, 50, 60, 80, 100 kDa. In group A they were found in 52% of 25 subjects, in group B in 44% of 25 subjects and they were not detected in group C. An improvement of hearing was recorded in 69% of subjects in group A. An improvement of hearing was observed in 72%, significant relief of vertigo in 81% of subjects in group B.
The present study supports the hypothesis of immune-mediated cochleovestibular disease (Tab. 3, Ref. 15).
本研究旨在通过证明抗内耳抗原抗体的存在来证实免疫反应参与某些耳蜗前庭疾病的发病机制,并确定免疫抑制治疗的益处。
1979年麦凯布提出了自身免疫性内耳疾病的假说。
采用十二烷基硫酸钠聚丙烯酰胺凝胶电泳和免疫印迹法检测74名受试者血清中抗内耳抗原抗体的存在情况。受试者分为三组:A组——特发性进行性感音神经性听力损失患者;B组——梅尼埃病患者;C组——健康受试者。检测出抗体阳性的个体接受免疫抑制治疗。
我们检测到分子量为30、50、60、80、100 kDa的抗内耳抗原抗体。A组25名受试者中有52%检测到抗体,B组25名受试者中有44%检测到抗体,C组未检测到抗体。A组69%的受试者听力有所改善。B组72%的受试者听力有所改善,81%的受试者眩晕明显缓解。
本研究支持免疫介导的耳蜗前庭疾病假说(表3,参考文献15)。